• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconWeight Loss

Weight Loss

Simple App as best intermittent fasting app
HealthThe Best Intermittent Fasting Apps of 2026: From Nutrition Experts
By Christina SnyderDecember 18, 2025
Noom as best weight loss program
HealthBest Weight Loss Programs of 2026: Expert Tested
By Christina SnyderDecember 18, 2025
Best weight loss program
HealthNoom Review (2026): Everything You Need to Know
By Christina SnyderDecember 12, 2025
Dr. Marty Makary, nominee to be commissioner of the U.S. Food and Drug Administration (FDA), appears before the Senate Health, Education, Labor and Pensions Committee for his confirmation hearing in the Dirksen Senate Office Building in Washington on Thursday, March 6, 2025. He was confirmed by the U.S. Senate on March 25, 2025.
HealthFDA warns Hims & Hers and other weight loss drugmakers to remove ‘false and misleading’ advertising
By The Associated PressSeptember 16, 2025
NewslettersExclusive: The founders of SoulCycle built a startup for relationships, then pivoted to GLP-1 support groups. Now its assets are being acquired by WeightWatchers
By Emma HinchliffeAugust 7, 2025
HealthWeight-loss drugs should be first step to prevent heart disease, top cardiology group says
By Michelle Amponsah and BloombergJune 20, 2025
Closeup of woman's torso in orange sweater holding injectable weight-loss drug.
LifestyleAgency warns that weight-loss drugs can decrease effectiveness of birth control pills
By Beth GreenfieldJune 5, 2025
HealthZepbound users lost nearly 50% more weight than those on Wegovy in first head-to-head study
By Jonel Aleccia and The Associated PressMay 12, 2025
Karsten Munk Knudsen, chief financial officer of Novo Nordisk A/S, at the company's headquarters in Bagsvaerd, Denmark, on Tuesday, Nov. 26, 2024.
HealthCurrency hedging and new U.S. factories: Novo Nordisk CFO thinks Wegovy maker can outmaneuver global trade wars
By Ryan HoggMay 9, 2025
FinanceWeightWatchers files for bankruptcy as it struggles for a place in a weight loss world dominated by Ozempic and Wegovy
By The Associated PressMay 7, 2025
HealthCVS strikes a deal to offer Wegovy at a discount
By Chris MorrisMay 1, 2025
Interest in GLP-1 medications like Ozempic will continue to grow given the multiple health conditions they can improve.
CommentaryThe crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up
By Wendy BarnesMarch 4, 2025
Close up of a man's face
Health50-year-old security guard lost 70 pounds on Wegovy—then gained two pants sizes when he lost insurance coverage
By Tom Murphy and The Associated PressFebruary 24, 2025
Semaglutide medications Wegovy and Ozempic are pictured
HealthWegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers
By Bloomberg, Madison Muller, Ike Swetlitz and Naomi KresgeFebruary 21, 2025
A woman injects herself with medication.
HealthOzempic, Wegovy maker calls out Hims & Hers Super Bowl ad: ‘Check before you inject’
By Lindsey LeakeFebruary 11, 2025
1
  • 1
  • 2
  • 3
  • 4
  • 5
6
Most Popular
Law
DOGE cancelled a $349,000 grant to replace a museum’s HVAC after ChatGPT flagged it as DEI, court documents showAn image of a popular article
By Fortune EditorsMarch 19, 2026
Economy
Social Security has 6 years left. The fix that sounds cruelest may be the smartestAn image of a popular article
By Fortune EditorsMarch 19, 2026
Success
Less than 10 out of 250 billionaires have kept their promise to give away their fortune—and a philanthropy CEO says Elon Musk is right about whyAn image of a popular article
By Fortune EditorsMarch 18, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.